| Tag | Content |
|---|
EnhancerAtlas ID | HS092-24134 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr2:65066950-65068030 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEF2C | MA0497.1 | chr2:65067626-65067641 | TTCTATTTCTAGCCC | - | 6 | | SOX10 | MA0442.2 | chr2:65067900-65067911 | AAAACAAAGAA | + | 6.62 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_00723 | chr2:65063555-65069256 | Adipose_Nuclei | | SE_09303 | chr2:65064566-65069966 | CD14 | | SE_10494 | chr2:65066427-65068370 | CD19_Primary | | SE_11245 | chr2:65064554-65070071 | CD20 | | SE_45951 | chr2:65063316-65068513 | Osteoblasts | | SE_53747 | chr2:65066675-65067868 | Spleen | | SE_62791 | chr2:65045447-65101119 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I064836 | chr2 | 65063814 | 65069733 |
|
Enhancer Sequence | TCCTCACCTG TGTACTGGGG ATGATATCGT GTATTTCATC AATTCTAGGA TGTGCAGCTT 60
TTTGCATCTT AATCTCTCTG AAATTGGGCT ATGTCTTACA GTTGATATGG GGGTAGGAGA 120
TGGTGTATTC CCACTCCTAG ATCGACTGTA GTGCCTCTAG GAGTGCCCTG CCAGAGAAGC 180
CCACACTCCA CCTCCTGAGC CAGGGTGGCC ATATGACTTG TCCTGGCCAA TGGAGTGTGA 240
AGCAAGCAAC ATCTATCACA TCCGGGCTGC ACTTTCAAAG GCAACTGTCG TTCAGCTCAT 300
GCTCCTTTTC ATCCACGTCA GCAGCCAGCA AAGTTCCAGA TGGAGGCTGT TTCGTGGGCC 360
CTGTCCCACA GTAAAGAGGA TGTAGAGCTG AGCTGCAGCT GGTGGGCATT GAACAGAAGC 420
ATAAACCTTT CTTCTTTAGC CATTGAGATT GGGGTTCTGT GTTTTGACAG CACAGTCTAG 480
CATATCCTGA CTGGTATTTC ATGCTCCAGT TAATTGACAG ATTCCTTTTT CTTTCTTAAT 540
ACATAGTGGT GTAACTCACA ATTGTTGGTA TTGTTGATTC AATGAAACAC GGTAGTGCCT 600
CTTACAGACT AATGTAGGTA AATCACTTAG CACAATGCCT GGCCCACAGT AAGTGTTCCA 660
TTCATGTTAG CCATTGTTCT ATTTCTAGCC CTCTGCATGT AGCCAATGTT TAATACATGC 720
TTGGAGGATG ATACTGATGA CACATGAGAT CAGAACCCCC CTTAGATCCC TTGTGGCATG 780
AGAAAGAGTA TCGTAAAAGA CAAAATTACA ACAAATTTAG TTTAAAGATC TCAACAAGCT 840
TTGTTGCAAT TCTAAAATTG GGCAACACTT CGTTCCATAA AACAGAATAA GTGTCCAATG 900
AACTGAGGAG AAGAGGCTGG CTTTACAGAC AGAAAAGGCT GAAGAAAGCA AAAACAAAGA 960
ACAAAAAGCA GATTGATCAT TTCAAAGTTA CTTGCCTTGT AAGGCGGGAC AGGGAGATGG 1020
AAGAGTAGAA AAATCACTGA TCAGTGAACC TTGTGTTACT TCGGGCTAAC TTTTGCATGT 1080
|
